Medical Education Library

Topic Highlights

COMMENTARY
• Perspectives on Seborrheic Dermatitis: Looking Back to Move Ahead
• Evaluation of a Nonsteroidal Topical Cream in a Guinea Pig Model of Malassezia Furfur Infection
• An Open-Label, Single-Center Pilot Study to Determine the Antifungal Activity of a New Nonsteroidal Cream (Promiseb Topical Cream) After 7 Days of Use in Healthy Volunteers
• An Investigator-Blind, Randomized, 4-Week, Parallel-Group, Multicenter Pilot Study to Compare the Safety and Efficacy of a Nonsteroidal Cream (Promiseb Topical Cream) and Desonide Cream 0.05% in the Twice-Daily Treatment of Mild to Moderate Seborrheic Dermatitis of the Face

Faculty/Faculty Disclosures

Guest Editor: James Q. Del Rosso, DO
Dermatologist
Las Vegas Skin and Cancer Clinics
Las Vegas, NV
Dr. Del Rosso is a consultant to, and serves as a speaker for Allergan Inc., Amgen Inc., Arcutis Pharmaceuticals, Coria Laboratories Ltd., Galderma Laboratories, L.P., Graceway Pharmaceuticals, LLC, Intendis, Inc., Medicis Pharmaceutical Corporation, Onset Therapeutics, OrthoNeutrogena, PharmaDerm, Quinnova Pharmaceuticals, Inc., Ranbaxy Laboratories, Ltd., Stiefel Laboratories, Inc., Triax Pharmaceuticals, LLC, Unilever and Warner Chilcott.

Boni E. Elewski, MD
Vice-Chair for Clinical Affairs
Professor of Dermatology
University of Alabama at Birmingham
Department of Dermatology
Birmingham, AL
San Diego, California
Dr. Elewski has received clinical grant funding from and is a consultant to Johnson & Johnson and Stiefel Laboratories, Inc.

Leon H. Kircik, MD, FAAD
Associate Clinical Professor of Dermatology
Indiana University Medical Center
Medical Director
DermResearch, PLLC
Louisville, KY
Dr. Kircik is a consultant, an investigator, and serves as a speaker for Promius.

Mr. Vijendra Nalamothu
Senior Director, Research & Development
Promius Pharma, LLC
Bridgewater, NJ
Mr. Nalamothu is an employee of Promius Pharma, LLC.

Ann L. O'Leary, PhD
Senior Manager
Ricerca Biosciences, LLC
Concord, OH
Dr. O'Leary has nothing to disclose.

Copyright © 2009 by Elsevier Inc.

Topic Highlights

COMMENTARY
• Perspectives on Seborrheic Dermatitis: Looking Back to Move Ahead
• Evaluation of a Nonsteroidal Topical Cream in a Guinea Pig Model of Malassezia Furfur Infection
• An Open-Label, Single-Center Pilot Study to Determine the Antifungal Activity of a New Nonsteroidal Cream (Promiseb Topical Cream) After 7 Days of Use in Healthy Volunteers
• An Investigator-Blind, Randomized, 4-Week, Parallel-Group, Multicenter Pilot Study to Compare the Safety and Efficacy of a Nonsteroidal Cream (Promiseb Topical Cream) and Desonide Cream 0.05% in the Twice-Daily Treatment of Mild to Moderate Seborrheic Dermatitis of the Face

Faculty/Faculty Disclosures

Guest Editor: James Q. Del Rosso, DO
Dermatologist
Las Vegas Skin and Cancer Clinics
Las Vegas, NV
Dr. Del Rosso is a consultant to, and serves as a speaker for Allergan Inc., Amgen Inc., Arcutis Pharmaceuticals, Coria Laboratories Ltd., Galderma Laboratories, L.P., Graceway Pharmaceuticals, LLC, Intendis, Inc., Medicis Pharmaceutical Corporation, Onset Therapeutics, OrthoNeutrogena, PharmaDerm, Quinnova Pharmaceuticals, Inc., Ranbaxy Laboratories, Ltd., Stiefel Laboratories, Inc., Triax Pharmaceuticals, LLC, Unilever and Warner Chilcott.

Boni E. Elewski, MD
Vice-Chair for Clinical Affairs
Professor of Dermatology
University of Alabama at Birmingham
Department of Dermatology
Birmingham, AL
San Diego, California
Dr. Elewski has received clinical grant funding from and is a consultant to Johnson & Johnson and Stiefel Laboratories, Inc.

Leon H. Kircik, MD, FAAD
Associate Clinical Professor of Dermatology
Indiana University Medical Center
Medical Director
DermResearch, PLLC
Louisville, KY
Dr. Kircik is a consultant, an investigator, and serves as a speaker for Promius.

Mr. Vijendra Nalamothu
Senior Director, Research & Development
Promius Pharma, LLC
Bridgewater, NJ
Mr. Nalamothu is an employee of Promius Pharma, LLC.

Ann L. O'Leary, PhD
Senior Manager
Ricerca Biosciences, LLC
Concord, OH
Dr. O'Leary has nothing to disclose.

Copyright © 2009 by Elsevier Inc.

Topic Highlights

COMMENTARY
• Perspectives on Seborrheic Dermatitis: Looking Back to Move Ahead
• Evaluation of a Nonsteroidal Topical Cream in a Guinea Pig Model of Malassezia Furfur Infection
• An Open-Label, Single-Center Pilot Study to Determine the Antifungal Activity of a New Nonsteroidal Cream (Promiseb Topical Cream) After 7 Days of Use in Healthy Volunteers
• An Investigator-Blind, Randomized, 4-Week, Parallel-Group, Multicenter Pilot Study to Compare the Safety and Efficacy of a Nonsteroidal Cream (Promiseb Topical Cream) and Desonide Cream 0.05% in the Twice-Daily Treatment of Mild to Moderate Seborrheic Dermatitis of the Face

Faculty/Faculty Disclosures

Guest Editor: James Q. Del Rosso, DO
Dermatologist
Las Vegas Skin and Cancer Clinics
Las Vegas, NV
Dr. Del Rosso is a consultant to, and serves as a speaker for Allergan Inc., Amgen Inc., Arcutis Pharmaceuticals, Coria Laboratories Ltd., Galderma Laboratories, L.P., Graceway Pharmaceuticals, LLC, Intendis, Inc., Medicis Pharmaceutical Corporation, Onset Therapeutics, OrthoNeutrogena, PharmaDerm, Quinnova Pharmaceuticals, Inc., Ranbaxy Laboratories, Ltd., Stiefel Laboratories, Inc., Triax Pharmaceuticals, LLC, Unilever and Warner Chilcott.

Boni E. Elewski, MD
Vice-Chair for Clinical Affairs
Professor of Dermatology
University of Alabama at Birmingham
Department of Dermatology
Birmingham, AL
San Diego, California
Dr. Elewski has received clinical grant funding from and is a consultant to Johnson & Johnson and Stiefel Laboratories, Inc.

Leon H. Kircik, MD, FAAD
Associate Clinical Professor of Dermatology
Indiana University Medical Center
Medical Director
DermResearch, PLLC
Louisville, KY
Dr. Kircik is a consultant, an investigator, and serves as a speaker for Promius.

Mr. Vijendra Nalamothu
Senior Director, Research & Development
Promius Pharma, LLC
Bridgewater, NJ
Mr. Nalamothu is an employee of Promius Pharma, LLC.

Ann L. O'Leary, PhD
Senior Manager
Ricerca Biosciences, LLC
Concord, OH
Dr. O'Leary has nothing to disclose.

Copyright © 2009 by Elsevier Inc.

A supplement to Skin & Allergy News®.

This supplement is sponsored by Ortho Dermatologics.

• Topic Highlights
• Faculty/Faculty Disclosures

To view the supplement, click the image.

Topics

MEDICAL DERMATOLOGY

• Acne From an Expert -- Drugs, Diet, and More
• New-Generation Topical Medications Harness Mighty Vehicles
• Effects of Uncontrolled Psoriasis Inflammation Are More Than Skin Deep
• Quick Diagnosis Key to Photodermatosis Outcomes

AESTHETIC DERMATOLOGY

• Scientific Treatment of Photoaging
• Periprocedure Considerations
• Look Beyond the Wrinkles in the Aging Face
• Fractionated Nonablative Lasers

PEDIATRIC DERMATOLOGY

• What’s Erupting: Acne Update
• Calm Parents’ Fears About Kids’ Sunscreens
• Persistent Diaper Dermatitis Could Signal More Serious Skin Condition
• What’s All the Pus About? Bacterial Infection Update

Chairs

Joseph F. Fowler, Jr, MD
Medical Dermatology Director
Clinical Professor of Dermatology
University of Louisville, Louisville, KY
Dermatology Specialists PSC, Louisville, KY

David J. Goldberg, MD, JD
Clinical Professor
Mount Sinai School of Medicine
Director
Skin & Laser Surgery Specialists of NY/NJ
New York, NY

Christopher B. Zachary, MBBS, FRCP
Professor and Chair
Department of Dermatology
University of California, Irvine, CA

Faculty/Faculty Disclosure

Joel L. Cohen, MD

Dr Cohen has industry affiliations as a consultant and clinical trials investigator with Allergan, Biopelle, Medicis, Merz, Neocutis, and Obagi.

Vincent DeLeo, MD
Dr DeLeo disclosed being a consultant for Estée Lauder, Goodyear, Limited Brands, L’Oréal, Neutrogena, Orfagen, Pfizer, and Schering-Plough

Lawrence F. Eichenfield, MD
Dr Eichenfield has worked on numerous clinical trials for various companies; he is an investigator for/has received grant/research support (no personal compensation received) from Galderma, Ortho Dermatologics, and Stiefel, a GlaxoSmithKline company. He is a consultant/advisor for Coria, Galderma, and Ortho Dermatologics.

Ilona Frieden, MD
Dr Frieden reported having no relevant conflicts of interest.

Sheila Fallon Friedlander, MD
Dr Friedlander has served as a clinical investigator for Johnson & Johnson, which manufactures sunscreen products.

David J. Goldberg, MD, JD
Dr Goldberg worked with Syneron™ (the manufacturers of the skin rejuvenation treatment Sublative Rejuvenation™).

Leon H. Kircik, MD
Dr Kircik has worked as an investigator, consultant, or speaker with the following pharmaceutical companies: Abbott, Acambis, Allergan, Amgen, Astellas, Asubio, Berlex, Biogen Idec, BioLife, Breckenridge Pharmaceutical, Centocor, ColBar LifeScience, CollaGenex Pharmaceuticals, Combinatrix, Connetics, Coria, Dermik, Dow, DUSA Pharmaceuticals, EOS Pharmaceutical, Ferndale, Galderma, Genentech, GlaxoSmithKline, Healthpoint, Innovail, Intendis, Johnson & Johnson, LEO Pharma, Medicis, NanoBio, Novartis, Nucryst, Obagi, Onset Therapeutics, OrthoNeutrogena, Pfizer, PharmaDerm, QLT, QuatRx, Quinnova Pharmaceuticals, Serono, SkinMedica, Stiefel, 3M, Tolerx, Triax Pharmaceuticals, UCB, Valeant, and Warner Chilcott.

Moise L. Levy, MD
Dr Levy discloses that he has worked as an investigator, consultant, and speaker for SkinMedica.

E. Victor Ross, MD
Dr Ross has worked as a consultant for and received a research grant from Palomar; has received research support and equipment from Cutera; and has received research support from Candela, Lumenis, Sciton, and Ulthera.

Jeffrey Sobell, MD
Dr Sobell disclosed that he is a speaker and consultant for Abbott, Amgen, and Centocor, and is an investigator for Abbott and Centocor. The companies are manufacturers of biologic treatments for psoriasis.

Guy Webster, MD, PhD
Dr Webster discloses industry affiliations with Allergan, Amgen, Astellas, Aventis, Bristol-Myers Squibb, Cipher, Coria, Cutanea Life Sciences, Dermik, Galderma, GlaxoSmithKline, Graceway, Johnson & Johnson, Medicis, Merck, Micrologix, NitricBio, Onset Therapeutics, Ortho, Ranbaxy, SkinMedica, Stiefel, Valocor  Therapeutics, Wyeth, and Xoma.

W. Philip Werschler, MD
Dr Werschler is a speaker, consultant, and clinical investigator for Allergan and Medicis, and has relationships with numerous other pharmaceutical companies.

Christopher B. Zachary, MBBS, FRCP
Dr Zachary has received grant support, honoraria, and discounted equipment from Cutera, Lumenis, Sciton, and Solta. He also discloses working with Allergan, Biopelle, Candela, Iridex, Primaeva, Reliant, Rhytec, Sciton, SkinMedica, Thermage, and Through the Lens.

Copyright © 2010 Elsevier Inc.

A supplement to Skin & Allergy News®.

This supplement is sponsored by Ortho Dermatologics.

• Topic Highlights
• Faculty/Faculty Disclosures

To view the supplement, click the image.

Topics

MEDICAL DERMATOLOGY

• Acne From an Expert -- Drugs, Diet, and More
• New-Generation Topical Medications Harness Mighty Vehicles
• Effects of Uncontrolled Psoriasis Inflammation Are More Than Skin Deep
• Quick Diagnosis Key to Photodermatosis Outcomes

AESTHETIC DERMATOLOGY

• Scientific Treatment of Photoaging
• Periprocedure Considerations
• Look Beyond the Wrinkles in the Aging Face
• Fractionated Nonablative Lasers

PEDIATRIC DERMATOLOGY

• What’s Erupting: Acne Update
• Calm Parents’ Fears About Kids’ Sunscreens
• Persistent Diaper Dermatitis Could Signal More Serious Skin Condition
• What’s All the Pus About? Bacterial Infection Update

Chairs

Joseph F. Fowler, Jr, MD
Medical Dermatology Director
Clinical Professor of Dermatology
University of Louisville, Louisville, KY
Dermatology Specialists PSC, Louisville, KY

David J. Goldberg, MD, JD
Clinical Professor
Mount Sinai School of Medicine
Director
Skin & Laser Surgery Specialists of NY/NJ
New York, NY

Christopher B. Zachary, MBBS, FRCP
Professor and Chair
Department of Dermatology
University of California, Irvine, CA

Faculty/Faculty Disclosure

Joel L. Cohen, MD

Dr Cohen has industry affiliations as a consultant and clinical trials investigator with Allergan, Biopelle, Medicis, Merz, Neocutis, and Obagi.

Vincent DeLeo, MD
Dr DeLeo disclosed being a consultant for Estée Lauder, Goodyear, Limited Brands, L’Oréal, Neutrogena, Orfagen, Pfizer, and Schering-Plough

Lawrence F. Eichenfield, MD
Dr Eichenfield has worked on numerous clinical trials for various companies; he is an investigator for/has received grant/research support (no personal compensation received) from Galderma, Ortho Dermatologics, and Stiefel, a GlaxoSmithKline company. He is a consultant/advisor for Coria, Galderma, and Ortho Dermatologics.

Ilona Frieden, MD
Dr Frieden reported having no relevant conflicts of interest.

Sheila Fallon Friedlander, MD
Dr Friedlander has served as a clinical investigator for Johnson & Johnson, which manufactures sunscreen products.

David J. Goldberg, MD, JD
Dr Goldberg worked with Syneron™ (the manufacturers of the skin rejuvenation treatment Sublative Rejuvenation™).

Leon H. Kircik, MD
Dr Kircik has worked as an investigator, consultant, or speaker with the following pharmaceutical companies: Abbott, Acambis, Allergan, Amgen, Astellas, Asubio, Berlex, Biogen Idec, BioLife, Breckenridge Pharmaceutical, Centocor, ColBar LifeScience, CollaGenex Pharmaceuticals, Combinatrix, Connetics, Coria, Dermik, Dow, DUSA Pharmaceuticals, EOS Pharmaceutical, Ferndale, Galderma, Genentech, GlaxoSmithKline, Healthpoint, Innovail, Intendis, Johnson & Johnson, LEO Pharma, Medicis, NanoBio, Novartis, Nucryst, Obagi, Onset Therapeutics, OrthoNeutrogena, Pfizer, PharmaDerm, QLT, QuatRx, Quinnova Pharmaceuticals, Serono, SkinMedica, Stiefel, 3M, Tolerx, Triax Pharmaceuticals, UCB, Valeant, and Warner Chilcott.

Moise L. Levy, MD
Dr Levy discloses that he has worked as an investigator, consultant, and speaker for SkinMedica.

E. Victor Ross, MD
Dr Ross has worked as a consultant for and received a research grant from Palomar; has received research support and equipment from Cutera; and has received research support from Candela, Lumenis, Sciton, and Ulthera.

Jeffrey Sobell, MD
Dr Sobell disclosed that he is a speaker and consultant for Abbott, Amgen, and Centocor, and is an investigator for Abbott and Centocor. The companies are manufacturers of biologic treatments for psoriasis.

Guy Webster, MD, PhD
Dr Webster discloses industry affiliations with Allergan, Amgen, Astellas, Aventis, Bristol-Myers Squibb, Cipher, Coria, Cutanea Life Sciences, Dermik, Galderma, GlaxoSmithKline, Graceway, Johnson & Johnson, Medicis, Merck, Micrologix, NitricBio, Onset Therapeutics, Ortho, Ranbaxy, SkinMedica, Stiefel, Valocor  Therapeutics, Wyeth, and Xoma.

W. Philip Werschler, MD
Dr Werschler is a speaker, consultant, and clinical investigator for Allergan and Medicis, and has relationships with numerous other pharmaceutical companies.

Christopher B. Zachary, MBBS, FRCP
Dr Zachary has received grant support, honoraria, and discounted equipment from Cutera, Lumenis, Sciton, and Solta. He also discloses working with Allergan, Biopelle, Candela, Iridex, Primaeva, Reliant, Rhytec, Sciton, SkinMedica, Thermage, and Through the Lens.

Copyright © 2010 Elsevier Inc.

A supplement to Skin & Allergy News®.

This supplement is sponsored by Ortho Dermatologics.

• Topic Highlights
• Faculty/Faculty Disclosures

To view the supplement, click the image.

Topics

MEDICAL DERMATOLOGY

• Acne From an Expert -- Drugs, Diet, and More
• New-Generation Topical Medications Harness Mighty Vehicles
• Effects of Uncontrolled Psoriasis Inflammation Are More Than Skin Deep
• Quick Diagnosis Key to Photodermatosis Outcomes

AESTHETIC DERMATOLOGY

• Scientific Treatment of Photoaging
• Periprocedure Considerations
• Look Beyond the Wrinkles in the Aging Face
• Fractionated Nonablative Lasers

PEDIATRIC DERMATOLOGY

• What’s Erupting: Acne Update
• Calm Parents’ Fears About Kids’ Sunscreens
• Persistent Diaper Dermatitis Could Signal More Serious Skin Condition
• What’s All the Pus About? Bacterial Infection Update

Chairs

Joseph F. Fowler, Jr, MD
Medical Dermatology Director
Clinical Professor of Dermatology
University of Louisville, Louisville, KY
Dermatology Specialists PSC, Louisville, KY

David J. Goldberg, MD, JD
Clinical Professor
Mount Sinai School of Medicine
Director
Skin & Laser Surgery Specialists of NY/NJ
New York, NY

Christopher B. Zachary, MBBS, FRCP
Professor and Chair
Department of Dermatology
University of California, Irvine, CA

Faculty/Faculty Disclosure

Joel L. Cohen, MD

Dr Cohen has industry affiliations as a consultant and clinical trials investigator with Allergan, Biopelle, Medicis, Merz, Neocutis, and Obagi.

Vincent DeLeo, MD
Dr DeLeo disclosed being a consultant for Estée Lauder, Goodyear, Limited Brands, L’Oréal, Neutrogena, Orfagen, Pfizer, and Schering-Plough

Lawrence F. Eichenfield, MD
Dr Eichenfield has worked on numerous clinical trials for various companies; he is an investigator for/has received grant/research support (no personal compensation received) from Galderma, Ortho Dermatologics, and Stiefel, a GlaxoSmithKline company. He is a consultant/advisor for Coria, Galderma, and Ortho Dermatologics.

Ilona Frieden, MD
Dr Frieden reported having no relevant conflicts of interest.

Sheila Fallon Friedlander, MD
Dr Friedlander has served as a clinical investigator for Johnson & Johnson, which manufactures sunscreen products.

David J. Goldberg, MD, JD
Dr Goldberg worked with Syneron™ (the manufacturers of the skin rejuvenation treatment Sublative Rejuvenation™).

Leon H. Kircik, MD
Dr Kircik has worked as an investigator, consultant, or speaker with the following pharmaceutical companies: Abbott, Acambis, Allergan, Amgen, Astellas, Asubio, Berlex, Biogen Idec, BioLife, Breckenridge Pharmaceutical, Centocor, ColBar LifeScience, CollaGenex Pharmaceuticals, Combinatrix, Connetics, Coria, Dermik, Dow, DUSA Pharmaceuticals, EOS Pharmaceutical, Ferndale, Galderma, Genentech, GlaxoSmithKline, Healthpoint, Innovail, Intendis, Johnson & Johnson, LEO Pharma, Medicis, NanoBio, Novartis, Nucryst, Obagi, Onset Therapeutics, OrthoNeutrogena, Pfizer, PharmaDerm, QLT, QuatRx, Quinnova Pharmaceuticals, Serono, SkinMedica, Stiefel, 3M, Tolerx, Triax Pharmaceuticals, UCB, Valeant, and Warner Chilcott.

Moise L. Levy, MD
Dr Levy discloses that he has worked as an investigator, consultant, and speaker for SkinMedica.

E. Victor Ross, MD
Dr Ross has worked as a consultant for and received a research grant from Palomar; has received research support and equipment from Cutera; and has received research support from Candela, Lumenis, Sciton, and Ulthera.

Jeffrey Sobell, MD
Dr Sobell disclosed that he is a speaker and consultant for Abbott, Amgen, and Centocor, and is an investigator for Abbott and Centocor. The companies are manufacturers of biologic treatments for psoriasis.

Guy Webster, MD, PhD
Dr Webster discloses industry affiliations with Allergan, Amgen, Astellas, Aventis, Bristol-Myers Squibb, Cipher, Coria, Cutanea Life Sciences, Dermik, Galderma, GlaxoSmithKline, Graceway, Johnson & Johnson, Medicis, Merck, Micrologix, NitricBio, Onset Therapeutics, Ortho, Ranbaxy, SkinMedica, Stiefel, Valocor  Therapeutics, Wyeth, and Xoma.

W. Philip Werschler, MD
Dr Werschler is a speaker, consultant, and clinical investigator for Allergan and Medicis, and has relationships with numerous other pharmaceutical companies.

Christopher B. Zachary, MBBS, FRCP
Dr Zachary has received grant support, honoraria, and discounted equipment from Cutera, Lumenis, Sciton, and Solta. He also discloses working with Allergan, Biopelle, Candela, Iridex, Primaeva, Reliant, Rhytec, Sciton, SkinMedica, Thermage, and Through the Lens.

Copyright © 2010 Elsevier Inc.

A supplement to Skin & Allergy News. This supplement was supported by Johnson & Johnson and is based on a presentation made at Skin Disease Education Foundation's 33rdAnnual Hawaii Dermatology SeminarTM.

• Topic Highlights
• Faculty/Faculty Disclosures

To view the supplement, click the image above.

• Aloe Vera
• Colloidal Oatmeal
• Feverfew
• Soy
• Tea
• Summary
Faculty/Faculty Disclosures

Joseph F. Fowler, Jr, MD
Clinical Professor of Dermatology
University of Louisville
Dermatology Specialists PSC
Louisville, Ky.
Dr. Fowler has received clinical grants from and is a consultant to Johnson & Johnson Family of Companies.

Copyright © 2009 by Elsevier Inc.

A supplement to Skin & Allergy News. This supplement was supported by Johnson & Johnson and is based on a presentation made at Skin Disease Education Foundation's 33rdAnnual Hawaii Dermatology SeminarTM.

• Topic Highlights
• Faculty/Faculty Disclosures

To view the supplement, click the image above.

• Aloe Vera
• Colloidal Oatmeal
• Feverfew
• Soy
• Tea
• Summary
Faculty/Faculty Disclosures

Joseph F. Fowler, Jr, MD
Clinical Professor of Dermatology
University of Louisville
Dermatology Specialists PSC
Louisville, Ky.
Dr. Fowler has received clinical grants from and is a consultant to Johnson & Johnson Family of Companies.

Copyright © 2009 by Elsevier Inc.

A supplement to Skin & Allergy News. This supplement was supported by Johnson & Johnson and is based on a presentation made at Skin Disease Education Foundation's 33rdAnnual Hawaii Dermatology SeminarTM.

• Topic Highlights
• Faculty/Faculty Disclosures

To view the supplement, click the image above.

• Aloe Vera
• Colloidal Oatmeal
• Feverfew
• Soy
• Tea
• Summary
Faculty/Faculty Disclosures

Joseph F. Fowler, Jr, MD
Clinical Professor of Dermatology
University of Louisville
Dermatology Specialists PSC
Louisville, Ky.
Dr. Fowler has received clinical grants from and is a consultant to Johnson & Johnson Family of Companies.

Copyright © 2009 by Elsevier Inc.

A supplement to Skin & Allergy News. This supplement was supported by Ortho Dermatologics.

• Topic Highlights
• Faculty/Faculty Disclosures

To view the supplement, click the image above.

• Technique
• Results
• Discussion
Faculty/Faculty Disclosures

J. Matthew Knight, MD, FAAD, MD
Knight Dermatology Institute
Orlando, FL, USA
Dr. Knight is a stockholder of Johnson & Johnson.

Copyright © 2009 by Elsevier Inc.

A supplement to Skin & Allergy News. This supplement was supported by Ortho Dermatologics.

• Topic Highlights
• Faculty/Faculty Disclosures

To view the supplement, click the image above.

• Technique
• Results
• Discussion
Faculty/Faculty Disclosures

J. Matthew Knight, MD, FAAD, MD
Knight Dermatology Institute
Orlando, FL, USA
Dr. Knight is a stockholder of Johnson & Johnson.

Copyright © 2009 by Elsevier Inc.

A supplement to Skin & Allergy News. This supplement was supported by Ortho Dermatologics.

• Topic Highlights
• Faculty/Faculty Disclosures

To view the supplement, click the image above.

• Technique
• Results
• Discussion
Faculty/Faculty Disclosures

J. Matthew Knight, MD, FAAD, MD
Knight Dermatology Institute
Orlando, FL, USA
Dr. Knight is a stockholder of Johnson & Johnson.

Copyright © 2009 by Elsevier Inc.